Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000359391

Medchemexpress LLC Gemigliptin tartrate hydrate | 1375415-82-9 | 99.8% | 666.49 | 100 MG
SDP

Catalog No. 5000359391
Encompass_Preferred

Gemigliptin (LC15-0444) tartrate hydrate is a selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. It exhibits potent anti-glycation properties and can be used for the research of advanced glycation end products (AGE)-related diabetic complications.

  • Selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor
  • Exhibits potent anti-glycation properties
  • Used for the research of advanced glycation end products (AGE)-related diabetic complications

Catalog No. 50-003-59391 Supplier Medchemexpress LLC Supplier No. HY14892B100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Gemigliptin (LC15-0444) tartrate hydrate is a selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. It exhibits potent anti-glycation properties and can be used for the research of advanced glycation end products (AGE)-related diabetic complications.

  • Selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor
  • Exhibits potent anti-glycation properties
  • Used for the research of advanced glycation end products (AGE)-related diabetic complications

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.